Back
Ultragenyx Pharmaceutical Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
59.07
Seasonality Move:
-0.7%
Buy
73
RYTM
Rhythm Pharmaceuticals
Last Price:
54.94
Seasonality Move:
11.04%
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $57.70. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $57.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $53.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.92 | Buy |
| Relative Strength Index (14 RSI): | 62.1 | Buy |
| Chaikin Money Flow: | -317060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.11 - 58.13) | Buy |
| Bollinger Bands (100): | (39.69 - 52.61) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.46 | Buy |
| Relative Strength Index (14 RSI): | 67.83 | Buy |
| Chaikin Money Flow: | -159819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.64 - 50.28) | Buy |
| Bollinger Bands (100): | (39.46 - 48.56) | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.5 | Buy |
| 20-day SMA: | 56.99 | Buy |
| 50-day SMA: | 51.17 | Buy |
| 200-day SMA: | 46.32 | Buy |
| 8-day EMA: | 57.7 | Sell |
| 20-day EMA: | 56.22 | Buy |
| 50-day EMA: | 52.28 | Buy |
| 200-day EMA: | 46.62 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.55 | Buy |
| 20-day SMA: | 48.38 | Buy |
| 50-day SMA: | 47.86 | Buy |
| 200-day SMA: | 43.39 | Buy |
| 8-day EMA: | 50.8 | Buy |
| 20-day EMA: | 49.06 | Buy |
| 50-day EMA: | 47.17 | Buy |
| 200-day EMA: | 41.51 | Buy |
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.
Ultragenyx Pharmaceutical Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||